Then, for XRCC4, overexpression of these genes was dramatically linked to worse PFS and OS for patients with serous ovarian carcinoma, HR=1.25 (1.07-1.46), P=0.004, HR=1.49 (1.27-1.74), P=0.0000. This evidence concerns the gene XRCC4 and ovarian serous carcinoma.